A phase III trial of PRV-002 to treat Traumatic-brain-injuries (concussion)
Latest Information Update: 06 Jun 2022
At a glance
- Drugs PRV-002 (Primary)
- Indications Traumatic brain injuries
- Focus Registrational; Therapeutic Use
- Sponsors Odyssey Health
- 06 Jun 2022 New trial record